| Product Code: ETC9945304 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market - Industry Life Cycle |
3.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market - Porter's Five Forces |
3.5 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume Share, By Stage, 2021 & 2031F |
3.7 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of gestational trophoblastic disease (GTD) in the UK |
4.2.2 Technological advancements in GTD treatment options |
4.2.3 Growing awareness and screening programs for early detection of GTD |
4.2.4 Supportive government initiatives and funding for research in GTD treatment |
4.2.5 Rising healthcare expenditure and focus on improving maternal health outcomes |
4.3 Market Restraints |
4.3.1 High cost associated with advanced GTD treatment therapies |
4.3.2 Limited availability of specialized healthcare facilities for GTD treatment |
4.3.3 Stringent regulatory requirements for approval of GTD treatment drugs |
4.3.4 Lack of skilled healthcare professionals specializing in GTD treatment |
4.3.5 Potential side effects and risks associated with certain GTD treatment modalities |
5 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Trends |
6 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market, By Types |
6.1 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Hydatidiform Moles, 2021- 2031F |
6.1.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Gestational Trophoblastic Neoplasia (Gtn ), 2021- 2031F |
6.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market, By Stage |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Stage 1, 2021- 2031F |
6.2.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Stage 2, 2021- 2031F |
6.2.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Stage 3, 2021- 2031F |
6.2.5 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Stage 4, 2021- 2031F |
6.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.3.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Generics, 2021- 2031F |
6.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.5 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.5.5 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.5 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Export to Major Countries |
7.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Imports from Major Countries |
8 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Key Performance Indicators |
8.1 Patient survival rates post-GTD treatment |
8.2 Adoption rate of novel GTD treatment technologies in clinical practice |
8.3 Average time from GTD diagnosis to initiation of treatment |
8.4 Patient satisfaction and quality of life post-treatment |
8.5 Rate of recurrence of GTD cases after treatment |
9 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market - Opportunity Assessment |
9.1 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Opportunity Assessment, By Stage, 2021 & 2031F |
9.3 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market - Competitive Landscape |
10.1 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Gestational Trophoblastic Disease (GTD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |